Why the study?
The study was conducted to assess risk factors for coronary artery stent thrombosis and restenosis and their anatomical localization in patients undergoing repeat revascularization during the COVID-19 pandemic.
Does prior COVID-19 infection increase the risk of coronary stent thrombosis and restenosis in patients requiring repeat revascularization?
Does prior COVID-19 infection increase the risk of coronary stent thrombosis and restenosis in patients requiring repeat revascularization?
Prior COVID-19 infection is a strong independent risk factor for coronary stent thrombosis in patients undergoing repeat revascularization.
Answers are grounded in this paper and cite their sources.
Prior COVID-19 infection was associated with stent thrombosis after PCI; hypothesis-generating and should not yet change practice.
Background: The aim of our study is to assess the risk factors for the development of coronary artery stent thrombosis and restenosis, as well as the main localization of these processes in patients who underwent repeated coronary revascularization during the COVID-19 pandemic. Materials and Methods: Data were retrospectively analyzed from 490 patients who underwent coronary angiography and required repeat revascularization from May 2020 to May 2023. The prevalence and anatomical distribution of coronary stenosis, restenosis, and stent thrombosis were assessed. Results: Coronary artery stenosis was detected in 46.9% of patients. The most affected arteries were the left anterior descending (13.7%), right coronary artery (15.1%), and circumflex branch (9.4%). In-stent restenosis was observed in 19.0% of cases. Coronary thrombosis occurred in 22.8% of patients, while stent thrombosis was found in 11.2%. Multivariate regression revealed that leukocyte count (OR = 1.18, p < 0.05), activated partial thromboplastin time (APTP) (OR = 1.021, p = 0.025), low-density lipoproteins (LDL) (OR = 1.421, p = 0.042), and prior COVID-19 infection (OR = 2.05, p = 0.038) were significant predictors of stent thrombosis. The left ventricular ejection fraction (LVEF) (OR = 0.959, p = 0.017) and hemoglobin levels (OR = 0.975, p = 0.014) have inverse association with risk of stent thrombosis. Conclusion: COVID-19 history is a strong independent risk factor for coronary stent thrombosis, alongside inflammatory and coagulation markers.
No takes yet. Share an insight, caveat, or question.
Ygiyeva et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: